Land: Slovenien
Sprog: engelsk
Kilde: HMA (Heads of Medicines Agencies)
enrofloxacin 25 mg/ml
aniMedica GmbH
QJ01MA90
Solution for injection
enrofloxacin
Cats Non Food, Dogs Non Food, Pigs Food, Rabbit Food
2012-07-25
1 von 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Enrotron 25, 25 mg/ml solution for injection for dogs, cats, pigs and rabbits 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: ACTIVE SUBSTANCE Enrofloxacin 25.0 mg EXCIPIENTS 1-Butanol 30.0 mg For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for injection. Clear, slightly yellowish to yellowish orange solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs Cats Pigs Rabbits 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of infectious diseases in pigs, dogs, cats and rabbits caused by the following enrofloxacin-susceptible gram-negative and gram-positive bacteria and mycoplasma: PIGS: - Diseases of the respiratory (enzootic pneumonia, pleuropneumonia) and alimentary tract (colidiarrhoea, colisepticemia) of bacterial or mycoplasmal origin _- E. coli, Pasteurella multocida, Mannheimia haemolytica, Mycoplasma hyopneumoni ae, _ _Actinobacillus pleuropneumoniae. _ _ _ DOGS AND CATS: - Treatment of bacterial single and mixed infections of the alimentary, respiratory and urogenital tracts, skin and wound infections _- E. coli, Salmonella _spp_., Pasteurella multocida, Mannheimia haemolytica, Haemophilus _spp_., _ _Staphylococcus _spp. RABBITS: - Treatment of bacterial single and mixed infections of the respiratory tract caused by _E. coli, _ _Pasteurella multocida, Staphylococcus aureus _ - Treatment of infections of the skin and wound infections caused by _Staphylococcus aureus._ Enrofloxacin should Læs hele dokumentet